EUVIMEDEUVIMED entdecken
Open Access

Dysregulated m 6 A via compensatory arginine methylation primes premalignancy in metabolic dysfunction–associated steatotic liver disease

Geun-Woo D Kim iD, Dahee Choi iD, Soo-Young Kim iD, Haengdueng Jeong iD, Geon Kang iD, So Jung Eom, Sangkyeong Eom iD, Jinyoung Park iD, Hye-Sook Lee, Insook Yang iD, Je Kyung Sung iD, Ki Taek Nam iD und 3 weitere

Science Advances · 2026

DOI: 10.1126/sciadv.aec5094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Geun-Woo D Kim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Life Sciences, Korea University, Seoul 02841, Korea. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Arginine, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Science and ICT, South Korea, Graduate School, Prince of Songkla University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) originates from premalignant disease-associated hepatocytes (daHeps) that emerge during the progression of metabolic dysfunction–associated steatotic liver disease (MASLD) to metabolic dysfunction–associated steatohepatitis (MASH). As daHeps are compensatorily primed by metabolic stress, we reproduced the accelerated progression of MASLD-associated HCC in mice by phenocopying the decreased expression of a metabolic regulator, protein arginine methyltransferase 1 (PRMT1). In Prmt1 liver-specific knockout (LKO), m 6 A-mediated changes in mRNA stability reprogram the transcriptome via paralog compensation; increased PRMT6 activates m 6 A methyltransferases by inducing asymmetric arginine dimethylation of METTL3. This event enhances global m 6 A deposition that leads to the down-regulation of Keap1 , which would trigger the NRF2 axis, promoting premalignancy; under diet- and chemical-induced stress, the incidence of steatohepatitic HCC was increased, clinically correlating with the PRMT-METTL3-NRF2 pathway. Together, we propose that compensatory arginine methylation primes MASLD-associated HCC by modulating m 6 A-mediated transcriptome and NRF2 regulatory pathways as adaptive defenses against metabolic and oxidative stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein-Arginine N-MethyltransferasesArginineLiver NeoplasmsCarcinoma, HepatocellularFatty LiverPrecancerous ConditionsAdenosineAnimalsMiceRNA MethylationEpitranscriptomeNF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1MethylationHumansMice, KnockoutRepressor Proteins

Substanzen

Protein-Arginine N-MethyltransferasesArgininePrmt1 protein, mousePRMT6 protein, mouseNF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1AdenosineKeap1 protein, mouseRepressor ProteinsNfe2l2 protein, mouse

Autor:innen und Institutionen

  • Division of Life Sciences, Korea University, Seoul 02841, Korea.
  • KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Korea.
  • Department of Molecular and Life Science, Hanyang University, Ansan, Korea.
  • Yonsei Biomedical Research Institute, Yonsei University College of Medicine, Seoul 03760, Korea.
  • Korea Model Animal Priority Center, Seoul National University, Seoul 08826, Korea.
  • Department of Biomedical Sciences, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul 03760, Korea.

ORCID-Profile: Geun-Woo D Kim, Dahee Choi, Soo-Young Kim, Haengdueng Jeong, Geon Kang, Sangkyeong Eom, Jinyoung Park, Insook Yang, Je Kyung Sung, Ki Taek Nam, Young Nyun Park, Sung Wook Chi, Seung-Hoi Koo

Förderung

  • Ministry of Science and ICT, South Korea
  • Graduate School, Prince of Songkla University

Zitieren

APA

Kim, G. D., Choi, D., Kim, S. Y., Jeong, H., Kang, G., Eom, S. J., Eom, S., Park, J., Lee, H. S., Yang, I., Sung, J. K., Nam, K. T., Park, Y. N., Chi, S. W., & Koo, S. H. (2026). Dysregulated m 6 A via compensatory arginine methylation primes premalignancy in metabolic dysfunction–associated steatotic liver disease. Science Advances. https://doi.org/10.1126/sciadv.aec5094

Vancouver

Kim GD, Choi D, Kim SY, Jeong H, Kang G, Eom SJ, et al. Dysregulated m 6 A via compensatory arginine methylation primes premalignancy in metabolic dysfunction–associated steatotic liver disease. Science Advances. 2026. doi:10.1126/sciadv.aec5094

BibTeX
@article{Kim2026,
  author = {Kim, Geun-Woo D and Choi, Dahee and Kim, Soo-Young and Jeong, Haengdueng and Kang, Geon and Eom, So Jung and Eom, Sangkyeong and Park, Jinyoung and Lee, Hye-Sook and Yang, Insook and Sung, Je Kyung and Nam, Ki Taek and Park, Young Nyun and Chi, Sung Wook and Koo, Seung-Hoi},
  title = {Dysregulated m 6 A via compensatory arginine methylation primes premalignancy in metabolic dysfunction–associated steatotic liver disease},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aec5094}
}
Kostenlos starten →